Woodline Partners’s Biodesix BDSX Stock Holding History

Woodline Partners’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-573	Closed	-$231K	–	432
2020 Q4	$231K	Buy	+573	New	+$178K	0.01%	216

Other funds holding BDSX

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

ACM

Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Woodline Partners's BDSX Position: Q1 2021 in Review

Woodline Partners sold out of Biodesix (BDSX) in Q1 2021, closing a stake of 573 shares — an estimated $231K sold.

Woodline Partners first reported a position in BDSX in Q4 2020 and held it in 1 quarter. The position peaked at $231K in Q4 2020. 46 funds tracked by Wall St. Rank hold BDSX as of Q1 2021.

Woodline Partners reported no remaining Biodesix position as of Q1 2021 after selling out during the quarter.
Woodline Partners sold 573 Biodesix shares in Q1 2021, an estimated $231K.
Woodline Partners first reported a position in Biodesix in Q4 2020 and held it in 1 quarter.
Woodline Partners's Biodesix position peaked at $231K in Q4 2020.
46 funds tracked by Wall St. Rank held Biodesix as of Q1 2021.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.